Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress
TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
Medical Devices
Sat, 25/05/2019 - 06:30
Tue, 21/05/2019 - 15:15
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovat
Thu, 24/01/2019 - 13:00
Call for the world’s greatest minds to tackle the world’s biggest killers
The British Heart Foundation’s Big Beat Challenge is now accepting proposals
Mon, 05/11/2018 - 07:30
Coventry, UK, 5th November 2018 / Sciad Newswire / Medherant, a developer of innovative transdermal drug delivery treat
Tue, 09/10/2018 - 15:00
London, UK, 9th October 2018 / Sciad Newswire / Following the success of last year's event, Ph
Wed, 03/10/2018 - 08:30
New funding to support manufacture of transdermal patches for clinical trials
Wed, 07/03/2018 - 07:30
Coventry, UK, 7th March 2018 / Sciad Newswire / Medherant Ltd, a leader in next-generation transdermal drug delivery, is
Thu, 08/02/2018 - 17:15
Brugg AG, Switzerland, 8th February 2018 / Sciad Newswire / Naviswiss, an independent medical technology company specialized in
Mon, 11/12/2017 - 10:00
Coventry, UK, 11th December 2017 / Sciad Newswire / Medherant, a leader in next-generation transdermal drug delivery, ha
Fri, 17/11/2017 - 15:25
Coventry, UK, 17th November 2017 / Sciad Newswire / Medherant is delighted to announce they have been awarded the ‘Excel